These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32176062)

  • 81. Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer.
    Cetin S; Dede I
    J Cancer Res Ther; 2020; 16(4):909-916. PubMed ID: 32930139
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer.
    Zhang J; Wang Y; Zhao T; Li Y; Tian L; Zhao J; Zhang J
    World J Surg Oncol; 2020 Feb; 18(1):31. PubMed ID: 32028958
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer.
    Liu L; Xu H; Wang W; Wu C; Chen Y; Yang J; Cen P; Xu J; Liu C; Long J; Guha S; Fu D; Ni Q; Jatoi A; Chari S; McCleary-Wheeler AL; Fernandez-Zapico ME; Li M; Yu X
    Int J Cancer; 2015 May; 136(9):2216-27. PubMed ID: 25273947
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Urinary gonadotropin peptide in patients with cancer of digestive organs.
    Motoo Y; Watanabe H; Yamaguchi Y; Mouri I; Fujii T; Yamakawa O; Satomura Y; Okai T; Sawabu N
    Anticancer Res; 1996; 16(4A):2041-8. PubMed ID: 8712740
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.
    Joergensen MT; Brünner N; De Muckadell OB
    Anticancer Res; 2010 Feb; 30(2):587-92. PubMed ID: 20332475
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
    Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
    Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
    [TBL] [Abstract][Full Text] [Related]  

  • 88. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.
    Jing R; Cui M; Ju S; Pan S
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255307
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ; Tao Z; Gu W; Sun LH
    Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.
    Lu Z; Peng J; Wang Z; Pan Z; Yuan Y; Wan D; Li B
    Med Oncol; 2016 Nov; 33(11):121. PubMed ID: 27722895
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Onset of liver metastasis after histologically curative resection of pancreatic cancer.
    Inoue K; Hiraoka T; Kanemitsu K; Takamori H; Tsuji T; Kawasuji M
    Surg Today; 2006; 36(3):252-6. PubMed ID: 16493535
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
    Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
    BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CT combined with tumor markers in the diagnosis and prognosis of hepatocellular carcinoma.
    Huang X; Li J; Wang F; Hao M
    J BUON; 2018; 23(4):985-991. PubMed ID: 30358203
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.
    Dong D; Jia L; Zhang L; Ma N; Zhang A; Zhou Y; Ren L
    Cancer Sci; 2018 Sep; 109(9):2841-2851. PubMed ID: 29945294
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.
    Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO
    Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875
    [TBL] [Abstract][Full Text] [Related]  

  • 97. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
    Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
    Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions.
    Chen M; Cao J; Bai Y; Tong C; Lin J; Jindal V; Barchi LC; Nadalin S; Yang SX; Pesce A; Panaro F; Ariche A; Kai K; Memeo R; Bekaii-Saab T; Cai X;
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00098. PubMed ID: 31663905
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Potential biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Kriz D; Ansari D; Andersson R
    Clin Transl Oncol; 2020 Dec; 22(12):2170-2174. PubMed ID: 32447642
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies.
    Yang Y; Yan S; Tian H; Bao Y
    Medicine (Baltimore); 2018 Mar; 97(9):e9994. PubMed ID: 29489701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.